Harper Molly, a director at Catalyst Pharmaceuticals ($CPRX), sold shares on the open market three times in the last year, totaling about $622 thousand. Her most recent sale occurred on December 12, 2025. These sales rank her 6,005th among 11,678 insiders in our database by total value sold, compared to an average of 8.6 million per insider across 6.4 transactions. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 29, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Restricted Stock Units | 1334 | $0.00 | 127,163.0000 | 127,201,954 | 1.04% | 0.00% |
| Dec. 29, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Common Stock, par value $0.001 per share | 1334 | $0.00 | 3,694.0000 | 127,201,954 | 56.53% | 0.00% |
| Dec. 12, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Common stock, par value $0.001 per share | 20000 | $5.78 | 29,106.0000 | 127,201,954 | 219.64% | 0.02% |
| Dec. 12, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | S | Common stock, par value $0.001 per share | 4473 | $23.73 | 9,106.0000 | 127,201,954 | 32.94% | 0.00% |
| Dec. 12, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | S | Common stock, par value $0.001 per share | 15527 | $23.20 | 13,579.0000 | 127,201,954 | 53.35% | 0.01% |
| Dec. 12, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Options to purchase common stock | 20000 | $0.00 | 128,497.0000 | 127,201,954 | 13.47% | 0.02% |
| Dec. 12, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | S | Common stock, par value $0.001 per share | 6746 | $23.06 | 2,360.0000 | 127,201,954 | 74.08% | 0.01% |
| Dec. 8, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Common Stock, par value $0.001 per share | 1413 | $0.00 | 9,106.0000 | 127,201,954 | 18.37% | 0.00% |
| Dec. 8, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Restricted Stock Units | 1413 | $0.00 | 148,497.0000 | 127,201,954 | 0.94% | 0.00% |
| Nov. 20, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | A | Restricted Stock Units | 5468 | $0.00 | 150,857.0000 | 127,201,954 | 3.76% | 0.00% |
| Nov. 21, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Common Stock, par value $0.001 per share | 947 | $0.00 | 7,693.0000 | 127,201,954 | 14.04% | 0.00% |
| Nov. 21, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Restricted Stock Units | 947 | $0.00 | 149,910.0000 | 127,201,954 | 0.63% | 0.00% |
| Nov. 20, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | A | Options to purchase common stock | 18115 | $0.00 | 145,389.0000 | 127,201,954 | 14.23% | 0.01% |
| Feb. 14, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Common Stock, par value $0.001 per share | 4000 | $0.00 | 6,746.0000 | 124,943,603 | 145.67% | 0.00% |
| Feb. 14, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Restricted Stock Units | 4000 | $0.00 | 127,274.0000 | 124,943,603 | 3.05% | 0.00% |
| Dec. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Restricted Stock Units | 1333 | $0.00 | 131,274.0000 | 125,407,279 | 1.01% | 0.00% |
| Dec. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Common Stock, par value $0.001 per share | 1333 | $0.00 | 2,746.0000 | 125,407,279 | 94.34% | 0.00% |
| Dec. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Restricted Stock Units | 1413 | $0.00 | 132,607.0000 | 125,407,279 | 1.05% | 0.00% |
| Dec. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Common Stock, par value $0.001 per share | 1413 | $0.00 | 1,413.0000 | 125,407,279 | 9999.99% | 0.00% |
| Nov. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Options to purchase common stock | 17500 | $0.00 | 134,020.0000 | 125,407,279 | 11.55% | 0.01% |
| Nov. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Common stock, par value $0.001 per share | 17500 | $5.78 | 17,500.0000 | 125,407,279 | 9999.99% | 0.01% |
| Nov. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | S | Common stock, par value $0.001 per share | 17500 | $22.00 | 0.0000 | 125,407,279 | 100.00% | 0.01% |
| Nov. 21, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | A | Options to purchase common stock | 23248 | $0.00 | 148,679.0000 | 125,407,279 | 18.53% | 0.02% |
| Nov. 21, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | A | Restricted Stock Units | 2841 | $0.00 | 151,520.0000 | 125,407,279 | 1.91% | 0.00% |
| June 3, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | S | Common Stock, par value $0.001 per share | 5333 | $16.30 | 0.0000 | 113,753,154 | 100.00% | 0.00% |
| Feb. 15, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Restricted Stock Units | 4000 | $0.00 | 125,431.0000 | 113,753,154 | 3.09% | 0.00% |
| Feb. 15, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Common Stock, par value $0.001 per share | 4000 | $0.00 | 5,333.0000 | 113,753,154 | 300.08% | 0.00% |
| Dec. 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Restricted Stock Units | 1333 | $0.00 | 129,431.0000 | 111,375,631 | 1.02% | 0.00% |
| Dec. 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Common Stock, par value $0.001 per share | 1333 | $0.00 | 1,333.0000 | 111,375,631 | 9999.99% | 0.00% |
| Dec. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | S | Common stock, par value $0.001 per share | 10000 | $14.37 | 0.0000 | 111,375,631 | 100.00% | 0.01% |
| Dec. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Options to purchase common stock | 10000 | $0.00 | 130,764.0000 | 111,375,631 | 7.10% | 0.01% |
| Dec. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Common stock, par value $0.001 per share | 10000 | $5.78 | 10,000.0000 | 111,375,631 | 9999.99% | 0.01% |
| Dec. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | S | Common stock, par value $0.001 per share | 4000 | $14.43 | 0.0000 | 111,375,631 | 100.00% | 0.00% |
| Dec. 8, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | A | Restricted Stock Units | 4240 | $0.00 | 140,764.0000 | 111,375,631 | 3.11% | 0.00% |
| Dec. 8, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | A | Options to purchase common stock | 29524 | $0.00 | 136,524.0000 | 111,375,631 | 27.59% | 0.03% |
| Feb. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Common Stock, par value $0.001 per share | 4000 | $0.00 | 4,000.0000 | 111,375,631 | 9999.99% | 0.00% |
| Feb. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Harper Molly | Director | M | Restricted Stock Units | 4000 | $0.00 | 107,000.0000 | 111,375,631 | 3.88% | 0.00% |